Syed Mohammad Ali Kazmi

Also affiliated with Southwestern Medical Center, The University of Texas Southwestern Medical Center

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Trastuzumab Plus Pertuzumab Versus Cetuximab Plus Irinotecan in Patients With RAS/BRAF Wild-Type, HER2-Positive, Metastatic Colorectal Cancer (S1613): A Randomized Phase II Trial”.

Trastuzumab Plus Pertuzumab Versus Cetuximab Plus Irinotecan in Patients With RAS/BRAF Wild-Type, HER2-Positive, Metastatic Colorectal Cancer (S1613): A Randomized Phase II Trial

Journal of Clinical Oncology(2025)10.1200/jco-24-01710

N/A

0.458DataRank · unranked

9 citations

Katherine A. Guthrie, Benjamin Tan, Crystal S. Denlinger, Marwan Fakih, Michael J. Overman +15 more

VEGFR2 activity on myeloid cells mediates immune suppression in the tumor microenvironment

JCI Insight(2021)10.1172/jci.insight.150735

N/A

0DataRank · unranked

55 citations

Huocong Huang, Morgan Coleman, Artūras Žiemys, Purva Gopal, Syed Mohammad Ali Kazmi +2 more

A Propensity Score Analysis of Chemotherapy Use in Patients With Resectable Gallbladder Cancer

JAMA Network Open(2022)10.1001/jamanetworkopen.2021.46912

N/A

0DataRank · unranked

41 citations

Suleyman Yasin Goksu, Nina N. Sanford, Matthew R. Porembka, Hajra Khurshid, Chul Ahn +4 more

A randomized phase 2 study of trastuzumab and pertuzumab (TP) compared to cetuximab and irinotecan (CETIRI) in advanced/metastatic colorectal cancer (mCRC) with HER2 amplification: SWOG S1613.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.4_suppl.140

N/A

0DataRank · unranked

7 citations

Katherine A. Guthrie, Scott Kopetz, Benjamin Tan, Crystal S. Denlinger, Marwan Fakih +15 more

A randomized trial of consolidation-targeted adjuvant therapy with encorafenib and cetuximab versus usual care for patients with stage II/III BRAF V600E colon cancer: Alliance for Clinical Trials in Oncology A022004.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps3641

N/A

0DataRank · unranked

6 citations

Qian Shi, Amylou C. Dueck, Elie G. Dib, Syed Mohammad Ali Kazmi, Olatunji B. Alese +6 more

Disparities in Colorectal Cancer Presentation at a National Cancer Institute-Designated Cancer Center and a Safety-Net Hospital during the COVID-19 Pandemic

Medical Research Archives(2024)10.18103/mra.v12i8.5761

N/A

0DataRank · unranked

0 citations

Megan Turley, Ofelia Negrete Vasquez, N Bryant, Baqir Baqir Jafry, Sitaram Chilakamarry +4 more